RU2013134359A - Комбинированная терапия с применением индуктора и ингибитора аутофагии для лечения новообразований - Google Patents
Комбинированная терапия с применением индуктора и ингибитора аутофагии для лечения новообразований Download PDFInfo
- Publication number
- RU2013134359A RU2013134359A RU2013134359/15A RU2013134359A RU2013134359A RU 2013134359 A RU2013134359 A RU 2013134359A RU 2013134359/15 A RU2013134359/15 A RU 2013134359/15A RU 2013134359 A RU2013134359 A RU 2013134359A RU 2013134359 A RU2013134359 A RU 2013134359A
- Authority
- RU
- Russia
- Prior art keywords
- use according
- inhibitor
- neoplasm
- agent
- autophagy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/531—Stem-loop; Hairpin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2010/062096 WO2012087336A1 (en) | 2010-12-23 | 2010-12-23 | Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2013134359A true RU2013134359A (ru) | 2015-01-27 |
Family
ID=46314300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013134359/15A RU2013134359A (ru) | 2010-12-23 | 2010-12-23 | Комбинированная терапия с применением индуктора и ингибитора аутофагии для лечения новообразований |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP2655619A4 (zh) |
| JP (1) | JP2014507129A (zh) |
| KR (1) | KR20130132956A (zh) |
| CN (1) | CN103403161A (zh) |
| BR (1) | BR112013015891A2 (zh) |
| CA (1) | CA2821378A1 (zh) |
| MX (1) | MX2013007171A (zh) |
| RU (1) | RU2013134359A (zh) |
| WO (1) | WO2012087336A1 (zh) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6052540B2 (ja) * | 2012-12-21 | 2016-12-27 | 国立大学法人福井大学 | Ａｔｇ７変異体を用いたオートファジーの抑制方法 |
| JP6441232B2 (ja) | 2012-12-27 | 2018-12-19 | サノフイＳａｎｏｆｉ | 抗ｌａｍｐ１抗体および抗体薬物コンジュゲート、ならびにその使用 |
| KR101461916B1 (ko) | 2013-11-04 | 2014-11-19 | 현대자동차 주식회사 | 커플드 토션 빔 액슬 타입 현가장치 |
| US11986480B2 (en) | 2017-02-03 | 2024-05-21 | Tohoku University | Heterocyclic compound |
| WO2018226776A1 (en) * | 2017-06-08 | 2018-12-13 | The Penn State Research Foundation | Assay for monitoring autophagosome completion |
| JPWO2019112014A1 (ja) * | 2017-12-07 | 2021-01-28 | パール工業株式会社 | 選定分子の導入方法および阻害剤を含有する組成物 |
| CN108103194B (zh) * | 2017-12-27 | 2021-05-18 | 中国医学科学院药用植物研究所 | 一种抑制胃癌细胞mgc-803的靶点及其应用 |
| KR102095749B1 (ko) * | 2018-12-20 | 2020-04-01 | 충남대학교 산학협력단 | S6k1 유전자 발현 억제제 또는 s6k1 단백질 활성 억제제를 유효성분으로 포함하는, 미토콘드리아 내 자가포식 장애로 발생되는 질병의 예방 또는 치료용 조성물 |
| CN111593068B (zh) * | 2019-01-28 | 2023-10-17 | 广州溯原生物科技股份有限公司 | 新型基因治疗载体pIRES-Rsirt2/4-Tet-nap的制备方法及应用 |
| CN110592044B (zh) * | 2019-07-26 | 2021-06-22 | 中国农业科学院蔬菜花卉研究所 | 蛋白激酶Fused编码基因及其在防治小菜蛾中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1856247B1 (en) * | 2005-01-19 | 2016-05-04 | The Trustees of The University of Pennsylvania | Regulation of autophagy and cell survival |
| JP2009502954A (ja) * | 2005-07-27 | 2009-01-29 | ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド | タンパク質のミスフォールディングを修正する小分子及びその使用 |
| UA95641C2 (en) * | 2006-07-06 | 2011-08-25 | Эррей Биофарма Инк. | Hydroxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| US8063050B2 (en) * | 2006-07-06 | 2011-11-22 | Array Biopharma Inc. | Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| US20100021420A1 (en) * | 2006-07-14 | 2010-01-28 | Astex Therapeutics Limited | Combinations of pyrazole derivatives for the inhibition of cdks and gsk's |
| US8476431B2 (en) * | 2008-11-03 | 2013-07-02 | Itellikine LLC | Benzoxazole kinase inhibitors and methods of use |
| EP2439274A4 (en) * | 2009-06-05 | 2013-11-06 | Dai-Wu Seol | MULTI-CISTRONIC shARN EXPRESSION CASSETTE FOR DELETING ONE OR MORE TARGET GENES |
-
2010
- 2010-12-23 WO PCT/US2010/062096 patent/WO2012087336A1/en active Application Filing
- 2010-12-23 EP EP10861010.6A patent/EP2655619A4/en not_active Withdrawn
- 2010-12-23 KR KR1020137019575A patent/KR20130132956A/ko not_active Application Discontinuation
- 2010-12-23 JP JP2013546098A patent/JP2014507129A/ja active Pending
- 2010-12-23 BR BR112013015891A patent/BR112013015891A2/pt not_active IP Right Cessation
- 2010-12-23 RU RU2013134359/15A patent/RU2013134359A/ru not_active Application Discontinuation
- 2010-12-23 CA CA2821378A patent/CA2821378A1/en not_active Abandoned
- 2010-12-23 MX MX2013007171A patent/MX2013007171A/es not_active Application Discontinuation
- 2010-12-23 CN CN2010800712519A patent/CN103403161A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012087336A1 (en) | 2012-06-28 |
| MX2013007171A (es) | 2013-11-04 |
| JP2014507129A (ja) | 2014-03-27 |
| EP2655619A1 (en) | 2013-10-30 |
| KR20130132956A (ko) | 2013-12-05 |
| BR112013015891A2 (pt) | 2016-10-04 |
| CN103403161A (zh) | 2013-11-20 |
| EP2655619A4 (en) | 2014-10-22 |
| CA2821378A1 (en) | 2012-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2013134359A (ru) | Комбинированная терапия с применением индуктора и ингибитора аутофагии для лечения новообразований | |
| RU2016108667A (ru) | Комбинированная терапия для лечения рака | |
| EA201992418A1 (ru) | Бициклические соединения и их применение в лечении рака | |
| JP2013534535A5 (zh) | ||
| DOP2015000244A (es) | Nuevos compuestos como inhibidores de reorganizado durante la transfección (ret) | |
| AR070865A1 (es) | Combinaciones de un conjugado anticuerpo- farmaco anti- her2 y agentes quimioterapeuticos y los metodos de uso | |
| NZ580009A (en) | Combination therapies comprising quinoxaline inhibitors of pi3k-alpha for use in the treatment of cancer | |
| RU2016123370A (ru) | Ингибитор контрольных точек и цельноклеточная микробактерия для использования при лечении онкологического заболевания | |
| RU2014124005A (ru) | Комбинация инотузумаба озогамицина и торизела для лечения рака | |
| RU2016102158A (ru) | Применение эрибулина и ленватиниба в качестве комбинированной терапии для лечения рака | |
| JP2013126979A5 (zh) | ||
| RU2018102080A (ru) | Комбинированная терапия противоопухолевым алкалоидом | |
| HRP20200076T1 (hr) | Kombinacijsko liječenje raka | |
| RU2015143106A (ru) | Терапия злокачественных опухолей | |
| EA201790546A1 (ru) | Производные пиридона в качестве ингибиторов киназы, реаранжированной во время трансфекции (ret) | |
| JP2010213710A5 (zh) | ||
| HRP20120661T1 (hr) | Derivati pirimidinil piridazinona | |
| HRP20211652T1 (hr) | Pirimidopirimidinoni korisni kao inhibitor wee-1 kinaze | |
| RU2014102935A (ru) | Кризотиниб для применения в лечении рака | |
| JP2020105190A5 (zh) | ||
| JP2019527231A5 (zh) | ||
| RU2018138626A (ru) | Комбинированная терапия ингибиторами notch и pi3k/mtor для применения в лечении рака | |
| MX2021014524A (es) | Metodos para tratar canceres del sistema urinario. | |
| HRP20170306T1 (hr) | Identifikacija izvanstaničnog oblika pten-a koj se može primjenjivati u liječenju tumora | |
| HRP20200734T1 (hr) | Derivat klorina koristan u fotodinamičkoj terapiji i dijagnozi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20151228 |